Cite
Clinical Imaging and Dosimetry of a Pan-Cancer Targeting Alkylphosphocholine Analog, [124I]I-NM404.
MLA
Grudzinski, Joseph J., et al. “Clinical Imaging and Dosimetry of a Pan-Cancer Targeting Alkylphosphocholine Analog, [124I]I-NM404.” Radiation, vol. 2, no. 2, June 2022, pp. 215–27. EBSCOhost, https://doi.org/10.3390/radiation2020015.
APA
Grudzinski, J. J., Hall, L. T., Cho, S., Glenn Liu, Traynor, A., Lee, M. H., Longino, M., Pinchuk, A., Jaskowiak, C., Bednarz, B., Weichert, J., & Kuo, J. S. (2022). Clinical Imaging and Dosimetry of a Pan-Cancer Targeting Alkylphosphocholine Analog, [124I]I-NM404. Radiation, 2(2), 215–227. https://doi.org/10.3390/radiation2020015
Chicago
Grudzinski, Joseph J., Lance T. Hall, Steve Cho, Glenn Liu, Anne Traynor, Matthew H. Lee, Marc Longino, et al. 2022. “Clinical Imaging and Dosimetry of a Pan-Cancer Targeting Alkylphosphocholine Analog, [124I]I-NM404.” Radiation 2 (2): 215–27. doi:10.3390/radiation2020015.